Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.34 USD | +0.84% | -12.12% | +83.66% |
14/05 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
13/05 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.66% | 291M | |
+63.04% | 62.59B | |
-1.21% | 41.18B | |
+44.76% | 40.29B | |
-8.29% | 27.9B | |
+13.14% | 26.21B | |
-21.51% | 19.09B | |
+5.43% | 13.08B | |
+25.21% | 12.26B | |
+28.39% | 12.05B |
- Stock Market
- Equities
- INO Stock
- News Inovio Pharmaceuticals, Inc.
- Inovio Pharma Reports Positive Preliminary Results in Recurrent Respiratory Papillomatosis Trial